Literature DB >> 10081684

Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.

J F Meis1, M Ruhnke, B E De Pauw, F C Odds, W Siegert, P E Verweij.   

Abstract

The recently described species Candida dubliniensis has been recovered primarily from superficial oral candidiasis in HIV-infected patients. No clinically documented invasive infections were reported until now in this patient group or in other immunocompromised patients. We report three cases of candidemia due to this newly emerging Candida species in HIV-negative patients with chemotherapy-induced immunosuppression and bone marrow transplantation.

Entities:  

Mesh：

Year:  1999        PMID： 10081684      PMCID： PMC2627682          DOI： 10.3201/eid0501.990119

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  7 in total

1.  Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.

Authors:  A Schoofs; F C Odds; R Colebunders; M Ieven; H Goossens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

Review 2.  Candidiasis: the emergence of a novel species, Candida dubliniensis.

Authors:  D C Coleman; D J Sullivan; D E Bennett; G P Moran; H J Barry; D B Shanley
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

3.  The epidemiology of hematogenous candidiasis caused by different Candida species.

Authors:  D Abi-Said; E Anaissie; O Uzun; I Raad; H Pinzcowski; S Vartivarian
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

Review 4.  Candida dubliniensis: an emerging opportunistic pathogen.

Authors:  D Sullivan; D Coleman
Journal:  Curr Top Med Mycol       Date:  1997-12

Review 5.  Candida dubliniensis: characteristics and identification.

Authors:  D Sullivan; D Coleman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

6.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

7.  Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans.

Authors:  E Pinjon; D Sullivan; I Salkin; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948
  7 in total
  46 in total

1.  First report of Candida dubliniensis in the Middle East.

Authors:  D A Stevens
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  One-year prevalence of Candida dublinienis in a Dutch university hospital.

Authors:  J F Meis; F M Lunel; P E Verweij; A Voss
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.

Authors:  M A Jabra-Rizk; W A Falkler; W G Merz; A A Baqui; J I Kelley; T F Meiller
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 4.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

5.  Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.

Authors:  Carolina Rodrigues Costa; Janine Aquino de Lemos; Xisto Sena Passos; Crystiane Rodrigues de Araújo; Ana Joaquina Cohen; Lúcia Kioko Hasimoto E Souza; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

6.  Methods of Candida dubliniensis identification and its occurrence in human clinical material.

Authors:  Martina Mahelová; Filip Růžička
Journal:  Folia Microbiol (Praha)       Date:  2017-05-17       Impact factor: 2.099

7.  Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicans.

Authors:  Jean O Kim; Lucille Garofalo; Deborah Blecker-Shelly; Karin L McGowan
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.

Authors:  Marcos Martinez; José L López-Ribot; William R Kirkpatrick; Brent J Coco; Stefano P Bachmann; Thomas F Patterson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Candida dubliniensis infection, Singapore.

Authors:  Ai Ling Tan; Grace C Y Wang; Yoon Wan Chiu
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

10.  One year prospective survey of Candida bloodstream infections in Scotland.

Authors:  Frank C Odds; Mary F Hanson; Amanda D Davidson; Mette D Jacobsen; Pauline Wright; Julie A Whyte; Neil A R Gow; Brian L Jones
Journal:  J Med Microbiol       Date:  2007-08       Impact factor: 2.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.